284 related articles for article (PubMed ID: 24107396)
21. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
22. [European guideline for the management of precancerous conditions in the stomach and it's application to Japan].
Haruma K; Kamada T; Murao T; Yamanaka Y; Ohsawa M; Shiotani A; Inoue K
Nihon Rinsho; 2013 Aug; 71(8):1479-84. PubMed ID: 23967683
[TBL] [Abstract][Full Text] [Related]
23. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
24. Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time.
Sipponen P; Kimura K
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S79-83. PubMed ID: 7735941
[TBL] [Abstract][Full Text] [Related]
25. Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up.
Zhang L; Liu Y; You P; Feng G
Scand J Gastroenterol; 2018; 53(7):843-848. PubMed ID: 29911441
[TBL] [Abstract][Full Text] [Related]
26. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
[TBL] [Abstract][Full Text] [Related]
27. Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies.
Areia M; Carvalho R; Cadime AT; Rocha Gonçalves F; Dinis-Ribeiro M
Helicobacter; 2013 Oct; 18(5):325-37. PubMed ID: 23566268
[TBL] [Abstract][Full Text] [Related]
28. H. pylori infection and gastric cancer: state of the art (review).
Conteduca V; Sansonno D; Lauletta G; Russi S; Ingravallo G; Dammacco F
Int J Oncol; 2013 Jan; 42(1):5-18. PubMed ID: 23165522
[TBL] [Abstract][Full Text] [Related]
29. Is screening for and surveillance of atrophic gastritis advisable?
Nardone G; Rocco A; Compare D; De Colibus P; Autiero G; Pica L; de Nucci G; Gasbarrini G
Dig Dis; 2007; 25(3):214-7. PubMed ID: 17827942
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori infection and precancerous lesions of the stomach.
Valle J; Gisbert JP
Hepatogastroenterology; 2001; 48(42):1548-51. PubMed ID: 11813569
[TBL] [Abstract][Full Text] [Related]
31. Gastric Cancer Screening in Common Variable Immunodeficiency.
van der Poorten DK; McLeod D; Ahlenstiel G; Read S; Kwok A; Santhakumar C; Bassan M; Culican S; Campbell D; Wong SWJ; Evans L; Jideh B; Kane A; Katelaris CH; Keat K; Ko Y; Lee JA; Limaye S; Lin MW; Murad A; Rafferty M; Suan D; Swaminathan S; Riminton SD; Toong C; Berglund LJ
J Clin Immunol; 2018 Oct; 38(7):768-777. PubMed ID: 30219982
[TBL] [Abstract][Full Text] [Related]
32. [Could Helicobacter pylori treatment reduce stomach cancer risk?].
Bretagne JF
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):440-52. PubMed ID: 12700501
[TBL] [Abstract][Full Text] [Related]
33. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
[TBL] [Abstract][Full Text] [Related]
34. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events.
Kabir S
Helicobacter; 2009 Jun; 14(3):159-71. PubMed ID: 19702845
[TBL] [Abstract][Full Text] [Related]
35. [Preneoplastic gastric lesions and helicobacter pylori in endoscopic detection and early diagnosis of gastric cancer in a population of a medium and high socio-economic level].
Chacaltana A; Rodríguez C; Urday C; Ramon W; Espinoza J; Velarde H; Rodríguez I; Lucho E; Rauch E
Rev Gastroenterol Peru; 2009; 29(3):218-25. PubMed ID: 19898593
[TBL] [Abstract][Full Text] [Related]
36. [Helicobacter pylori and gastric cancer].
León-Barúa R; Recavarren-Arce S; Berendson R; Gilman RH
Rev Gastroenterol Peru; 1995; 15 Suppl 1():S23-7. PubMed ID: 8520017
[TBL] [Abstract][Full Text] [Related]
37. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
38. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP.
Cubiella J; Pérez Aisa Á; Cuatrecasas M; Díez Redondo P; Fernández Esparrach G; Marín-Gabriel JC; Moreira L; Núñez H; Pardo López ML; Rodríguez de Santiago E; Rosón P; Sanz Anquela JM; Calvet X;
Gastroenterol Hepatol; 2021 Jan; 44(1):67-86. PubMed ID: 33252332
[TBL] [Abstract][Full Text] [Related]
39. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection.
de Vries AC; Haringsma J; Kuipers EJ
Helicobacter; 2007 Feb; 12(1):1-15. PubMed ID: 17241295
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K
Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]